These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 7722242

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.
    Kon CH, Occleston NL, Charteris D, Daniels J, Aylward GW, Khaw PT.
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1524-9. PubMed ID: 9660504
    [Abstract] [Full Text] [Related]

  • 23. [Cytological study of subretinal fluid].
    Xu X, He Z.
    Zhonghua Yan Ke Za Zhi; 1997 Nov; 33(6):450-2. PubMed ID: 10680550
    [Abstract] [Full Text] [Related]

  • 24. [Proliferative vitreoretinopathy--selected issues concerning morphology and pathophysiology].
    Laudańska-Olszewska I, Omulecki W.
    Klin Oczna; 2006 Nov; 108(1-3):87-9. PubMed ID: 16883949
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology.
    Charteris DG, Sethi CS, Lewis GP, Fisher SK.
    Eye (Lond); 2002 Jul; 16(4):369-74. PubMed ID: 12101443
    [Abstract] [Full Text] [Related]

  • 28. [Ultrastructural characteristics of epiretinal membranes].
    Wang F, Yan Y, Zhang X, Cai W.
    Zhonghua Yan Ke Za Zhi; 1999 Nov; 35(6):440-2, 24. PubMed ID: 11835856
    [Abstract] [Full Text] [Related]

  • 29. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells.
    Casaroli-Marano RP, Pagan R, Vilaró S.
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262
    [Abstract] [Full Text] [Related]

  • 30. Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy.
    Sethi CS, Lewis GP, Fisher SK, Leitner WP, Mann DL, Luthert PJ, Charteris DG.
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):329-42. PubMed ID: 15623793
    [Abstract] [Full Text] [Related]

  • 31. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
    Laudańska-Olszewska I, Omulecki W, Dziegielewski K, Pikulski Z, Omulecka A.
    Klin Oczna; 2006 Jan; 108(1-3):28-31. PubMed ID: 16883935
    [Abstract] [Full Text] [Related]

  • 32. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
    Zhang X, Barile G, Chang S, Hays A, Pachydaki S, Schiff W, Sparrow J.
    Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
    [Abstract] [Full Text] [Related]

  • 33. [Vitronectin: mediator of cell adhesion in proliferative vitreoretinopathy?].
    Weller M, Wiedemann P, Bresgen M, Heimann K.
    Fortschr Ophthalmol; 1990 May; 87(2):221-5. PubMed ID: 1694159
    [Abstract] [Full Text] [Related]

  • 34. Upregulation of extracellular ATP-induced Müller cell responses in a dispase model of proliferative vitreoretinopathy.
    Francke M, Weick M, Pannicke T, Uckermann O, Grosche J, Goczalik I, Milenkovic I, Uhlmann S, Faude F, Wiedemann P, Reichenbach A, Bringmann A.
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):870-81. PubMed ID: 11867610
    [Abstract] [Full Text] [Related]

  • 35. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
    Briggs MC, Grierson I, Hiscott P, Hunt JA.
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
    [Abstract] [Full Text] [Related]

  • 36. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy.
    Lashkari K, Rahimi N, Kazlauskas A.
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):149-56. PubMed ID: 9888438
    [Abstract] [Full Text] [Related]

  • 37. [Immunohistochemical findings in proliferative retinal diseases--on the significance of fibronectin, macrophages and transferrin].
    Weller M, Heimann K, Wiedemann P.
    Fortschr Ophthalmol; 1989 Jan; 86(2):121-3. PubMed ID: 2661370
    [Abstract] [Full Text] [Related]

  • 38. [Subretinal proliferation and rhegmatogenous retinal detachment].
    Bonnet M, Hajjar C, Fleury J.
    J Fr Ophtalmol; 1993 Jan; 16(4):235-40. PubMed ID: 8326103
    [Abstract] [Full Text] [Related]

  • 39. [Proliferative vitreoretinal reaction].
    Kampik A.
    Fortschr Med; 1984 Jan 26; 102(4):75-8. PubMed ID: 6698469
    [Abstract] [Full Text] [Related]

  • 40. [Functional and morphological features of vitreoretinal proliferation after penetrating wounds of eye complicated by hemophthalmos (immunohistochemical and electron microscopy study)].
    Khoroshilova-Maslova IP, Andreeva LD, Bykov VP, Chichua GA.
    Vestn Oftalmol; 1998 Jan 26; 114(6):10-4. PubMed ID: 9951376
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.